117 related articles for article (PubMed ID: 32013983)
1. A stratification method based on clustering for the minimization of data masking effect in signal detection.
Wei JX; Ding Y; Li M; Sun J
BMC Med Inform Decis Mak; 2020 Feb; 20(1):18. PubMed ID: 32013983
[TBL] [Abstract][Full Text] [Related]
2. Assessing the extent and impact of the masking effect of disproportionality analyses on two spontaneous reporting systems databases.
Maignen F; Hauben M; Hung E; Van Holle L; Dogne JM
Pharmacoepidemiol Drug Saf; 2014 Feb; 23(2):195-207. PubMed ID: 24243665
[TBL] [Abstract][Full Text] [Related]
3. An Exploratory Study of the Impact of COVID-19 Vaccine Spontaneous Reporting on Masking Signal Detection in EudraVigilance.
Micallef B; Dogné JM; Sultana J; Straus SMJM; Nisticò R; Serracino-Inglott A; Borg JJ
Drug Saf; 2023 Nov; 46(11):1089-1103. PubMed ID: 37707778
[TBL] [Abstract][Full Text] [Related]
4. Impact of stratification on adverse drug reaction surveillance.
Hopstadius J; Norén GN; Bate A; Edwards IR
Drug Saf; 2008; 31(11):1035-48. PubMed ID: 18840023
[TBL] [Abstract][Full Text] [Related]
5. Safety related drug-labelling changes: findings from two data mining algorithms.
Hauben M; Reich L
Drug Saf; 2004; 27(10):735-44. PubMed ID: 15350157
[TBL] [Abstract][Full Text] [Related]
6. Drug Safety Monitoring in Children: Performance of Signal Detection Algorithms and Impact of Age Stratification.
Osokogu OU; Dodd C; Pacurariu A; Kaguelidou F; Weibel D; Sturkenboom MC
Drug Saf; 2016 Sep; 39(9):873-81. PubMed ID: 27255487
[TBL] [Abstract][Full Text] [Related]
7. Detection of cluster adverse drug events in the spontaneous reporting system of China using a disproportionality filter algorithm.
Wang M; Ye X; Ruan Y; Xu J; Guo X; Dong D; Feng H; He J
J Clin Pharm Ther; 2019 Dec; 44(6):952-957. PubMed ID: 31407823
[TBL] [Abstract][Full Text] [Related]
8. Quantitative signal detection for vaccines: effects of stratification, background and masking on GlaxoSmithKline's spontaneous reports database.
Zeinoun Z; Seifert H; Verstraeten T
Hum Vaccin; 2009 Sep; 5(9):599-607. PubMed ID: 19617701
[TBL] [Abstract][Full Text] [Related]
9. A Method for the Minimization of Competition Bias in Signal Detection from Spontaneous Reporting Databases.
Arnaud M; Salvo F; Ahmed I; Robinson P; Moore N; Bégaud B; Tubert-Bitter P; Pariente A
Drug Saf; 2016 Mar; 39(3):251-60. PubMed ID: 26715499
[TBL] [Abstract][Full Text] [Related]
10. Criteria revision and performance comparison of three methods of signal detection applied to the spontaneous reporting database of a pharmaceutical manufacturer.
Matsushita Y; Kuroda Y; Niwa S; Sonehara S; Hamada C; Yoshimura I
Drug Saf; 2007; 30(8):715-26. PubMed ID: 17696584
[TBL] [Abstract][Full Text] [Related]
11. Outlier removal to uncover patterns in adverse drug reaction surveillance - a simple unmasking strategy.
Juhlin K; Ye X; Star K; Norén GN
Pharmacoepidemiol Drug Saf; 2013 Oct; 22(10):1119-29. PubMed ID: 23832706
[TBL] [Abstract][Full Text] [Related]
12. Supervised signal detection for adverse drug reactions in medication dispensing data.
Hoang T; Liu J; Roughead E; Pratt N; Li J
Comput Methods Programs Biomed; 2018 Jul; 161():25-38. PubMed ID: 29852965
[TBL] [Abstract][Full Text] [Related]
13. Novel Adverse Events of Iloperidone: A Disproportionality Analysis in US Food and Drug Administration Adverse Event Reporting System (FAERS) Database.
Subeesh V; Maheswari E; Singh H; Beulah TE; Swaroop AM
Curr Drug Saf; 2019; 14(1):21-26. PubMed ID: 30362421
[TBL] [Abstract][Full Text] [Related]
14. Masking by vaccines in pediatric drug safety signal detection in the EudraVigilance database.
Dodd C; Pacurariu A; Osokogu OU; Weibel D; Ferrajolo C; Vo DH; Becker B; Kors JA; Sturkenboom M
Pharmacoepidemiol Drug Saf; 2018 Nov; 27(11):1249-1256. PubMed ID: 30066460
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
[TBL] [Abstract][Full Text] [Related]
16. A conceptual approach to the masking effect of measures of disproportionality.
Maignen F; Hauben M; Hung E; Holle LV; Dogne JM
Pharmacoepidemiol Drug Saf; 2014 Feb; 23(2):208-17. PubMed ID: 24243699
[TBL] [Abstract][Full Text] [Related]
17. Comparison of statistical signal detection methods within and across spontaneous reporting databases.
Candore G; Juhlin K; Manlik K; Thakrar B; Quarcoo N; Seabroke S; Wisniewski A; Slattery J
Drug Saf; 2015 Jun; 38(6):577-87. PubMed ID: 25899605
[TBL] [Abstract][Full Text] [Related]
18. Applying quantitative methods for detecting new drug safety signals in pharmacovigilance national database.
Shalviri G; Mohammad K; Majdzadeh R; Gholami K
Pharmacoepidemiol Drug Saf; 2007 Oct; 16(10):1136-40. PubMed ID: 17705214
[TBL] [Abstract][Full Text] [Related]
19. Towards early detection of adverse drug reactions: combining pre-clinical drug structures and post-market safety reports.
Liu R; Zhang P
BMC Med Inform Decis Mak; 2019 Dec; 19(1):279. PubMed ID: 31849321
[TBL] [Abstract][Full Text] [Related]
20. The value of time-to-onset in statistical signal detection of adverse drug reactions: a comparison with disproportionality analysis in spontaneous reports from the Netherlands.
Scholl JH; van Puijenbroek EP
Pharmacoepidemiol Drug Saf; 2016 Dec; 25(12):1361-1367. PubMed ID: 27686554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
